These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20384656)

  • 1. Isolated potentials and pace-mapping as guides for ablation of ventricular tachycardia in various types of nonischemic cardiomyopathy.
    Kühne M; Abrams G; Sarrazin JF; Crawford T; Good E; Chugh A; Ebinger M; Jongnarangsin K; Pelosi F; Oral H; Morady F; Bogun FM
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1017-23. PubMed ID: 20384656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated potentials during sinus rhythm and pace-mapping within scars as guides for ablation of post-infarction ventricular tachycardia.
    Bogun F; Good E; Reich S; Elmouchi D; Igic P; Lemola K; Tschopp D; Jongnarangsin K; Oral H; Chugh A; Pelosi F; Morady F
    J Am Coll Cardiol; 2006 May; 47(10):2013-9. PubMed ID: 16697318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of ventricular tachycardia in patients with nonischemic cardiomyopathy.
    Bogun F; Morady F
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1227-30. PubMed ID: 18691235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density mapping of ventricular scar: a comparison of ventricular tachycardia (VT) supporting channels with channels that do not support VT.
    Nayyar S; Wilson L; Ganesan AN; Sullivan T; Kuklik P; Chapman D; Brooks AG; Mahajan R; Baumert M; Young GD; Sanders P; Roberts-Thomson KC
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):90-8. PubMed ID: 24382409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological mapping and radiofrequency catheter ablation for ventricular tachycardia in a patient with peripartum cardiomyopathy.
    Tokuda M; Stevenson WG; Nagashima K; Rubin DA
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1299-301. PubMed ID: 24102817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
    Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular tachycardia originating from the posterior papillary muscle in the left ventricle: a distinct clinical syndrome.
    Doppalapudi H; Yamada T; McElderry HT; Plumb VJ; Epstein AE; Kay GN
    Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):23-9. PubMed ID: 19808390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation.
    Vergara P; Trevisi N; Ricco A; Petracca F; Baratto F; Cireddu M; Bisceglia C; Maccabelli G; Della Bella P
    J Cardiovasc Electrophysiol; 2012 Jun; 23(6):621-7. PubMed ID: 22486970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia.
    Hsia HH; Callans DJ; Marchlinski FE
    Circulation; 2003 Aug; 108(6):704-10. PubMed ID: 12885746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ventricular synchronized triggered atrial pacing to facilitate hemodynamic support during mapping and catheter ablation of ventricular vachycardia.
    Piccini JP; Koontz JI; Jackson KP
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1174-8. PubMed ID: 21371159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter ablation of ventricular tachycardia in nonischemic heart disease.
    Tokuda M; Tedrow UB; Kojodjojo P; Inada K; Koplan BA; Michaud GF; John RM; Epstein LM; Stevenson WG
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):992-1000. PubMed ID: 22942218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End points for ablation of scar-related ventricular tachycardia.
    Santangeli P; Frankel DS; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):949-60. PubMed ID: 25336365
    [No Abstract]   [Full Text] [Related]  

  • 13. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
    Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction.
    Verma A; Marrouche NF; Schweikert RA; Saliba W; Wazni O; Cummings J; Abdul-Karim A; Bhargava M; Burkhardt JD; Kilicaslan F; Martin DO; Natale A
    J Cardiovasc Electrophysiol; 2005 May; 16(5):465-71. PubMed ID: 15877614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECG criteria to identify epicardial ventricular tachycardia in nonischemic cardiomyopathy.
    Vallès E; Bazan V; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):63-71. PubMed ID: 20008307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the ventricular tachycardia isthmus after infarction by pace mapping.
    Brunckhorst CB; Delacretaz E; Soejima K; Maisel WH; Friedman PL; Stevenson WG
    Circulation; 2004 Aug; 110(6):652-9. PubMed ID: 15289385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy.
    Cano O; Hutchinson M; Lin D; Garcia F; Zado E; Bala R; Riley M; Cooper J; Dixit S; Gerstenfeld E; Callans D; Marchlinski FE
    J Am Coll Cardiol; 2009 Aug; 54(9):799-808. PubMed ID: 19695457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and utility of discrete great arterial potentials in the ablation of outflow tract ventricular arrhythmias.
    Srivathsan KS; Bunch TJ; Asirvatham SJ; Edwards WD; Friedman PA; Munger TM; Hammill SC; Cha YM; Brady PA; Jahangir A; Bradley DJ; Rea RF; Packer DL; Shen WK
    Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):30-8. PubMed ID: 19808391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular scar-related ventricular tachycardia in nonischemic cardiomyopathy: Electrophysiological characteristics, mapping, and ablation of underlying heart disease.
    Kumar S; Baldinger SH; Kapur S; Romero J; Mehta NK; Mahida S; Fujii A; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):79-89. PubMed ID: 28940781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT).
    Tung R; Josephson ME; Reddy V; Reynolds MR;
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):799-803. PubMed ID: 20132389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.